WallStSmart

Corteva Inc (CTVA)vsNutrien Ltd (NTR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nutrien Ltd generates 50% more annual revenue ($26.88B vs $17.89B). NTR leads profitability with a 8.9% profit margin vs 6.5%. NTR appears more attractively valued with a PEG of 1.21. NTR earns a higher WallStSmart Score of 67/100 (B-).

CTVA

Buy

64

out of 100

Grade: C+

Growth: 4.7Profit: 5.5Value: 4.0Quality: 6.0
Piotroski: 4/9Altman Z: 1.49

NTR

Strong Buy

67

out of 100

Grade: B-

Growth: 6.7Profit: 6.0Value: 5.3Quality: 6.0
Piotroski: 6/9Altman Z: 1.73
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CTVASignificantly Overvalued (-73.4%)

Margin of Safety

-73.4%

Fair Value

$44.32

Current Price

$77.46

$33.14 premium

UndervaluedFair: $44.32Overvalued
NTRSignificantly Overvalued (-31.4%)

Margin of Safety

-31.4%

Fair Value

$55.61

Current Price

$67.20

$11.59 premium

UndervaluedFair: $55.61Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CTVA4 strengths · Avg: 8.5/10
Market CapQuality
$50.64B9/10

Large-cap with strong market position

Debt/EquityHealth
0.149/10

Conservative balance sheet, low leverage

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

Operating MarginProfitability
23.7%8/10

Strong operational efficiency at 23.7%

NTR4 strengths · Avg: 9.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

EPS GrowthGrowth
1250.0%10/10

Earnings expanding 1250.0% YoY

P/E RatioValuation
13.7x8/10

Attractively priced relative to earnings

Revenue GrowthGrowth
19.0%8/10

19.0% revenue growth

Areas to Watch

CTVA4 concerns · Avg: 2.5/10
Return on EquityProfitability
4.8%3/10

ROE of 4.8% — below average capital efficiency

Profit MarginProfitability
6.5%3/10

6.5% margin — thin

P/E RatioValuation
40.9x2/10

Premium valuation, high expectations priced in

Free Cash FlowQuality
$-2.97B2/10

Negative free cash flow — burning cash

NTR2 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.734/10

Distress zone — elevated risk

Free Cash FlowQuality
$-1.13B2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : CTVA

The strongest argument for CTVA centers on Market Cap, Debt/Equity, Price/Book. Revenue growth of 11.0% demonstrates continued momentum. PEG of 1.27 suggests the stock is reasonably priced for its growth.

Bull Case : NTR

The strongest argument for NTR centers on Price/Book, EPS Growth, P/E Ratio. Revenue growth of 19.0% demonstrates continued momentum. PEG of 1.21 suggests the stock is reasonably priced for its growth.

Bear Case : CTVA

The primary concerns for CTVA are Return on Equity, Profit Margin, P/E Ratio. A P/E of 40.9x leaves little room for execution misses.

Bear Case : NTR

The primary concerns for NTR are Altman Z-Score, Free Cash Flow.

Key Dynamics to Monitor

CTVA profiles as a value stock while NTR is a growth play — different risk/reward profiles.

NTR carries more volatility with a beta of 1.06 — expect wider price swings.

NTR is growing revenue faster at 19.0% — sustainability is the question.

NTR generates stronger free cash flow (-1.1B), providing more financial flexibility.

Bottom Line

NTR scores higher overall (67/100 vs 64/100) and 19.0% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Corteva Inc

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Corteva, Inc. (also known as Corteva Agriscience) is a major American agricultural chemical and seed company that was the agricultural unit of DowDuPont prior to being spun off as an independent public company.

Visit Website →

Nutrien Ltd

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Nutrien Ltd. provides inputs, services and solutions for crops. The company is headquartered in Saskatoon, Canada.

Visit Website →

Want to dig deeper into these stocks?